Related Experiment Video
Updated: May 31, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
Chaperone-mediated autophagy is a tumor-suppressive mechanism in hepatocellular carcinoma
Khushbu Patel1, Begoña Zapateria1, Alexander J Ledet2
1Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Department of Medicine and The Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Abstract:
Chaperone-mediated autophagy (CMA) is a selective lysosomal pathway essential for proteostasis and stress adaptation that declines with aging and metabolic disease, conditions closely linked to hepatocellular carcinoma (HCC). Using genetically engineered mouse models with systemic, hepatocyte-specific, or T cell-specific deletion of the CMA regulator LAMP2A in an MYC-driven, TP53-deficient HCC context, we demonstrate that CMA exerts cell-type-dependent tumor-suppressive functions. Hepatocyte-intrinsic CMA loss promotes early malignant transformation, whereas T cell-specific CMA deficiency impairs early immune-mediated tumor control but is also required to sustain tumor growth. Proteomic profiling identifies the cohesin complex component STAG2 as a putative CMA substrate that accumulates in CMA-dysregulated hepatocytes, a finding validated in human HCC tissues, shown to drive cell cycle dysregulation and proliferation, contributing to hepatocarcinogenesis. These results establish CMA as a dual hepatocyte- and immune-dependent mechanism that suppresses liver tumorigenesis and positions STAG2 as a CMA-controlled node with therapeutic relevance in HCC.
Insights
Chaperone-mediated autophagy (CMA) loss promotes liver cancer by impairing cell-type-specific tumor suppression. CMA dysregulation and STAG2 accumulation drive hepatocarcinogenesis, highlighting CMA
Area of Science:
- Cellular Biology
- Molecular Biology
- Cancer Research
Background:
- Chaperone-mediated autophagy (CMA) is a vital lysosomal pathway for maintaining proteostasis and adapting to stress.
- CMA function declines with aging and metabolic diseases, which are risk factors for hepatocellular carcinoma (HCC).
Purpose of the Study:
- To investigate the cell-type-dependent role of CMA in hepatocellular carcinoma (HCC) development.
- To identify molecular mechanisms by which CMA loss contributes to hepatocarcinogenesis.
Main Methods:
- Utilized genetically engineered mouse models with specific deletions of the CMA regulator LAMP2A in hepatocytes or T cells within an MYC-driven, TP53-deficient HCC model.
- Performed proteomic profiling to identify CMA substrates.
- Validated findings in human HCC tissues.
Main Results:
- Hepatocyte-specific CMA loss accelerated early malignant transformation.
- T cell-specific CMA deficiency initially impaired tumor immunity but later supported tumor growth.
- Accumulation of STAG2, a cohesin complex component, was observed in CMA-dysregulated hepatocytes and human HCC tissues.
- STAG2 accumulation was linked to cell cycle dysregulation and increased proliferation.
Conclusions:
- CMA plays a dual role in suppressing liver tumorigenesis, dependent on both hepatocytes and the immune system.
- STAG2 is a key CMA-controlled molecule implicated in HCC development.
- Targeting CMA or STAG2 may offer therapeutic strategies for HCC.
More Related Videos
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Abnormal Proliferation
Cellular Injury V: Apoptosis and Autophagy
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

